-Dow Jones
What Wall Street Thinks Of Twitter’s Disappointing Quarter
Analysts were left with many questions after Twitter Inc (NYSE: TWTR) reported first quarter earnings. Future concerns exist, leading to several price target cuts.
Related Posts
Clene’s Amyotrophic Lateral Sclerosis Candidate Disappoints In Mid-Stage Study
Clene Inc (NASDAQ:CLNN) has announced topline data from RESCUE-ALS phase 2 trial evaluating CNM-Au8 for early amyotrophic lateral sclerosis (ALS). The…
BioCryst Gets FDA Fast Track Designation For Bone Formation Disorder Candidate
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BioCryst Pharmaceuticals's (NASDAQ: BCRX) lead drug candidate BCX9250 for the prevention of heterotopic ossification (HO) in patients with fibrodysplasia ossificans progressiva (FOP).
$100 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much
Microchip Technology (NASDAQ:MCHP) has outperformed the market over the past 90 days by 8.6%, generating a 11.43% return for its investors over the time period. Now, given this information, it may seem like price appreciation alone is the best way to have made money on this stock, that's not actually the case.